Analyst Ratings for Concert Pharmaceuticals (CNCE) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/2/2021 | Mizuho | Vamil Divan | New Coverage | Buy (N/A) |
9.00 (N/A) |
3.38 (8.37) |
147.63% | Details |
| 12/16/2020 | Berenberg » Updated 5/23/2022 |
Esther Hong | New Coverage | Buy (N/A) |
11.00 (N/A) |
12.79 (8.37) |
-34.56% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
